PPARγ is thought to be a “master” gene of adipocyte biology and differentiation17, and various PPARγ agonists including thiazolidinediones have been used as insulin sensitizers for the treatment of type 2 diabetes. Here, PPARG is linked to type 2 diabetes mellitus.